(Q38571859)

4 September 2017

title

Antihypertensive Therapies and Cognitive Function: a Review (English)

1 reference

4 September 2017

Nisharahmed Kherada

1

1 reference

4 September 2017

Todd Heimowitz

series ordinal

2

1 reference

4 September 2017

Clive Rosendorff

series ordinal

3

1 reference

4 September 2017

publication date

1 October 2015

1 reference

Current Hypertension Reports

4 September 2017

published in

1 reference

4 September 2017

volume

17

1 reference

4 September 2017

issue

10

1 reference

4 September 2017

page(s)

79

1 reference

Cardiovascular Risk Factors for Alzheimer's Disease

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Hypertension, brain damage and cognitive decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

The worldwide economic impact of dementia 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Are antihypertensive agents protective against dementia? A review of clinical and preclinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Blood pressure and treatment of persons with hypertension as it relates to cognitive outcomes including executive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Pharmacological blood pressure lowering in the older hypertensive patients may lead to cognitive impairment by altering neurovascular coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Hypertension and cerebral vasoreactivity: a continuous arterial spin labeling magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Hypertension, white matter hyperintensities, and concurrent impairments in mobility, cognition, and mood: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

White matter lesions and lacunar infarcts are independently and differently associated with brain atrophy: the SMART-MR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Elevated pulse pressure is associated with age-related decline in language ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

The ACE Insertion Deletion polymorphism relates to dementia by metabolic phenotype, APOEepsilon4, and age of dementia onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Lewis K. Dahl memorial lecture: the renin-angiotensin system and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Midlife cardiovascular risk factors and risk of dementia in late life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Midlife blood pressure and dementia: the Honolulu-Asia aging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Association between dementia and midlife risk factors: the Radiation Effects Research Foundation Adult Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Alerting, orienting, and executive attention in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Low systolic blood pressure is associated with impaired cognitive function in the oldest old: longitudinal observations in a population-based sample 80 years and older.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Hypertension and cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Exaggeration of focal cerebral ischemia in transgenic mice carrying human Renin and human angiotensinogen genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Continuous activation of renin-angiotensin system impairs cognitive function in renin/angiotensinogen transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Renin-angiotensin-aldosterone system has a pivotal role in cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Multiple cellular and molecular mechanisms are involved in human Aβ clearance by transplanted adult astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Brain renin angiotensin in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

The effects of antihypertensive treatment on cognitive function: results from the HOPE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

The pathophysiologic role of the brain renin-angiotensin system in stroke protection: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Renin-angiotensin system in the brain as a new target of antihypertensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Antihypertensive medication use and incident Alzheimer disease: the Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Diuretic use is associated with better learning and memory in older adults in the Ginkgo Evaluation of Memory Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Use of calcium antagonists and cognitive decline in old age. The Leiden 85-plus study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Effect of nimodipine on memory after cerebral infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Carvedilol as a potential novel agent for the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Propranolol restores cognitive deficits and improves amyloid and Tau pathologies in a senescence-accelerated mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Effects of beta-blockade and exercise on cardiovascular and cognitive functioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Influence of losartan and atenolol on memory function in very elderly hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Antihypertensive medication use and risk of cognitive impairment: the Honolulu-Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Long-term effects of secondary prevention on cognitive function in stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0592-7

15-year longitudinal study of blood pressure and dementia

21 January 2018

1 reference

12 December 2020

Brain renin-angiotensin system in cognitive function: pre-clinical findings and implications for prevention and treatment of dementia.

1 reference

12 December 2020

Carvedilol reestablishes long-term potentiation in a mouse model of Alzheimer's disease

1 reference

12 December 2020

Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study.

1 reference

12 December 2020

Metabolic substrates of neuronal aging

1 reference

12 December 2020

The renin-angiotensin system and antihypertensive drugs in Alzheimer's disease: current standing of the angiotensin hypothesis?

1 reference

12 December 2020

Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. The Research Committee of Disorders of Adrenal Hormones in Japan

1 reference

12 December 2020

The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study

1 reference

12 December 2020

Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia

1 reference

12 December 2020

10.1007/S11906-015-0592-7

Identifiers

DOI

1 reference

Dimensions Publication ID

4 September 2017

1041169343

0 references

1 reference